Clincosm LogoSign in Get a demo

Depression

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bipolar I Disorder, Mania, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar I Disorder
  • +2 more
  • Little Rock, Arkansas
  • +111 more
Dec 12, 2022

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
Has Results
  • Bipolar Disorder
  • Depression
  • Little Rock, Arkansas
  • +73 more
Jan 10, 2019

Depression Trial in Worldwide (Armodafinil)

Terminated
Has Results
  • Depression
  • Birmingham, Alabama
  • +157 more
Aug 23, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +143 more
Sep 14, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (Brexpiprazole, Seroquel XR, Placebo)

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +75 more
May 10, 2018

Depression, Depressive Disorder, Depressive Disorder, Treatment-resistant Trial in United States (LFMS)

Completed
Has Results
  • Depression
  • +3 more
  • LFMS
  • Garden Grove, California
  • +11 more
Oct 31, 2017

Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,

Terminated
Has Results
  • Sexual Dysfunctions, Psychological
  • Depression
  • flibanserin 50 mg to 100 mg qhs
  • +2 more
  • Costa Mesa, California
  • +41 more
Jul 14, 2016

Depression Trial in United States (Armodafinil, Placebo)

Completed
Has Results
  • Depression
  • Birmingham, Alabama
  • +39 more
Apr 26, 2016

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • OPC-34712 + ADT
  • Placebo + ADT
  • Arcadia, California
  • +56 more
Oct 26, 2015

Anxiety Disorder, Breast Cancer, Depression Trial in United States (gabapentin, quality-of-life assessment)

Completed
  • Anxiety Disorder
  • +3 more
  • Mobile, Alabama
  • +17 more
Oct 13, 2015

Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)

Terminated
  • Depression
  • Birmingham, Alabama
  • +143 more
Sep 23, 2015

Depression Trial in Worldwide (Duloxetine, Placebo matching with BMS-820836, BMS-820836)

Completed
  • Depression
  • Little Rock, Arkansas
  • +83 more
Sep 23, 2015

MDD, Depression Trial in India, United States (TC-5214, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Depression
  • Tuscaloosa, Alabama
  • +50 more
Mar 14, 2014

MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • Birmingham, Alabama
  • +93 more
Mar 14, 2014

Depression, Depressive Disorder, Depressive Disorder, Major Trial in United States (Desvenlafaxine administered as a succinate

Completed
Has Results
  • Depression
  • +2 more
  • Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR)
  • Placebo
  • Birmingham, Alabama
  • +36 more
Apr 9, 2012

Depression Trial in United States (duloxetine, fluoxetine, citalopram)

Completed
Has Results
  • Depression
  • Carson, California
  • +60 more
May 12, 2010